» Articles » PMID: 28502017

Comparative Analysis of Immune Effects in Mice Model: Clonorchis Sinensis Cysteine Protease Generated from Recombinant Escherichia Coli and Bacillus Subtilis Spores

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2017 May 15
PMID 28502017
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Clonorchiasis remains a nonnegligible public health problem in endemic areas. Cysteine protease of Clonorchis sinensis (CsCP) plays indispensable roles in the parasitic physiology and pathology, and has been exploited as a promising drug and vaccine candidate. In recent years, development of spore-based vaccines against multiple pathogens has attracted many investigators' interest. In previous studies, the recombinant Escherichia coli (BL21) and Bacillus subtilis spores expressing CsCP have been successfully constructed, respectively. In this study, the immune effects of CsCP protein purified from recombinant BL21 (rCsCP) and B. subtilis spores presenting CsCP (B.s-CsCP) in Balb/c mice model were conducted with comparative analysis. Levels of specific IgG, IgG1 and IgG2a were significantly increased in sera from both rCsCP and B.s-CsCP intraperitoneally immunized mice. Additionally, recombinant spores expressing abundant fusion CsCP (0.03125 pg/spore) could strongly enhance the immunogenicity of CsCP with significantly higher levels of IgG and isotypes. Compared with rCsCP alone, intraperitoneal administration of mice with spores expressing CsCP achieved a better effect of fighting against C. sinensis infection by slowing down the process of fibrosis. Our results demonstrated that a combination of Th1/Th2 immune responses could be elicited by rCsCP, while spores displaying CsCP prominently induced Th1-biased specific immune responses, and the complex cytokine network maybe mediates protective immune responses against C. sinensis. This work further confirmed that the usage of B. subtilis spores displaying CsCP is an effective way to against C. sinensis.

Citing Articles

Mechanisms and Applications of Bacterial Sporulation and Germination in the Intestine.

Koopman N, Remijas L, Seppen J, Setlow P, Brul S Int J Mol Sci. 2022; 23(6).

PMID: 35328823 PMC: 8953710. DOI: 10.3390/ijms23063405.


The storage stability of Bacillus subtilis spore displaying cysteine protease of Clonorchis sinensis and its effect on improving the gut microbiota of mice.

Tang Z, Wu Z, Sun H, Zhao L, Shang M, Shi M Appl Microbiol Biotechnol. 2021; 105(6):2513-2526.

PMID: 33606075 DOI: 10.1007/s00253-021-11126-z.


Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4'-diaponeurosporene-producing .

Jing Y, Liu H, Xu W, Yang Q Exp Ther Med. 2017; 14(6):6069-6073.

PMID: 29285159 PMC: 5740520. DOI: 10.3892/etm.2017.5282.

References
1.
Xu Y, Liang P, Bian M, Chen W, Wang X, Lin J . Interleukin-13 is involved in the formation of liver fibrosis in Clonorchis sinensis-infected mice. Parasitol Res. 2016; 115(7):2653-60. DOI: 10.1007/s00436-016-5012-7. View

2.
El-Ahwany E, Rabia I, Nagy F, Zoheiry M, Diab T, Zada S . Protective role of purified cysteine proteinases against Fasciola gigantica infection in experimental animals. Korean J Parasitol. 2012; 50(1):45-51. PMC: 3309050. DOI: 10.3347/kjp.2012.50.1.45. View

3.
Qu H, Xu Y, Sun H, Lin J, Yu J, Tang Z . Systemic and local mucosal immune responses induced by orally delivered Bacillus subtilis spore expressing leucine aminopeptidase 2 of Clonorchis sinensis. Parasitol Res. 2014; 113(8):3095-103. DOI: 10.1007/s00436-014-3975-9. View

4.
Lee J, Kim I, Sohn W, Lee J, Yong T . Vaccination with DNA encoding cysteine proteinase confers protective immune response to rats infected with Clonorchis sinensis. Vaccine. 2006; 24(13):2358-66. DOI: 10.1016/j.vaccine.2005.11.062. View

5.
Hong H, Huang J, Khaneja R, Hiep L, Urdaci M, Cutting S . The safety of Bacillus subtilis and Bacillus indicus as food probiotics. J Appl Microbiol. 2008; 105(2):510-20. DOI: 10.1111/j.1365-2672.2008.03773.x. View